GRANULES INDIA
Back to Income Statement
|
GRANULES INDIA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹502 Cr | ₹405 Cr | ₹517 Cr | ₹413 Cr | ₹549 Cr |
What is the latest Consolidated Net Profit of GRANULES INDIA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹502 Cr |
| Mar2024 | ₹405 Cr |
| Mar2023 | ₹517 Cr |
| Mar2022 | ₹413 Cr |
| Mar2021 | ₹549 Cr |
How is Consolidated Net Profit of GRANULES INDIA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹502 Cr | 23.74 | |
| Mar2024 | ₹405 Cr | -21.54 | |
| Mar2023 | ₹517 Cr | 25.16 | |
| Mar2022 | ₹413 Cr | -24.88 | |
| Mar2021 | ₹549 Cr | - | |
Compare Consolidated Net Profit of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹14,045.0 Cr | -0.4% | -3.6% | -0.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.2% | -1.3% | -3.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 1.9% | -6.7% | 0.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 1.3% | 2.9% | 28.7% | Stock Analytics | |
| CIPLA | ₹109,030.0 Cr | 1.3% | -8.5% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 1.3% | 3.8% | 4.5% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -0.4% |
-3.6% |
-0.4% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses